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to be demonstrated. A better description of PE in a SA setting 
would be useful in efforts to improve patient management and 
subsequent patient outcomes in this setting. Therefore, the 
aim of this research was to improve the current understanding 
of PE in a SA setting. The objectives of this research were to: 
(1) Determine the most common presenting characteristics of 
PE in patients who were admitted to a tertiary SA hospital 
with the condition (the case series - CS); (2) determine the 
inpatient mortality in the CS; and (3) discuss similarities and 
differences related to PE between SA and overseas settings. 
MATERIALS AND METHODS
Research design, setting, and patients 
This was a CS of adult patients who were admitted with a 
primary diagnosis of PE to the tertiary-level Inkosi Albert Luthuli 
Central Hospital (IALCH) in Durban, SA, over a 5-year period 
(1 January 2011 - 31 December 2015). The population served 
by IALCH is predominantly of black African ethnicity. The 
INTRODUCTION
Pulmonary embolism (PE) is an important complication of deep 
vein thrombosis (DVT).(1) Both PE and DVT are manifesta-
tions of venous thromboembolism (VTE). An incidence rate 
of nearly 1.0 case per 1 000 people has been reported for 
PE in North American/European settings.(2) Mortality is much 
higher in patients with undiagnosed, untreated PE.(3) Therefore, 
a better understanding of the presentation of PE is required, 
such that patients can be diagnosed timeously and treatment 
can be initiated.(4) However, the presentation of PE itself is 
highly variable and can pose diagnostic challenges.(2,4,5) While 
there are no specific data available for PE in a South African 
(SA) setting, a 2007 report found 2 566 deaths in the country 
could be attributed to diseases of the circulatory system – a 
composite measure that includes PE, stroke, and myocardial 
infarction.(6) Interestingly, embolic pathophysiology also appears 
to play some role in stroke and myocardial infarction.(7,8) While 
descriptions of PE in SA settings are rare, recent evidence from 
a study of DVT in a SA setting suggests that there might be 
some setting-specific differences in the characteristics and risk 
factors for VTE between SA and overseas settings.(9) It is pos-
sible that there might be some discordance between the 
characteristics, risk factors, and mortality associated with PE 
between SA settings and overseas settings. However, this is yet 
ABSTRACT
Background: Published reports of pulmonary embolism 
(PE) from South African (SA) settings are rare. We 
sought to address this paucity in the literature.
Methods: This case series (CS) involved 61 adult patients 
admitted to a tertiary SA hospital over a fi ve-year period 
with a primary diagnosis of PE. Data related to patient 
demographics, PE presentation, risk factors, treatment, 
and inpatient mortality were collected, and then 
analysed using descriptive statistics. 
Results: Most of our CS were aged <65 years (86.9%), 
female (67.2%), and of black African ethnicity (73.8%). 
Dyspnoea and chest pain were the most common 
symptoms (86.9% and 41.0%, respectively). Common 
clinical signs included tachypnea (47.5%) and tachycardia 
(42.6%). Common established risk factors were cardiac 
failure (49.2%) and obesity (27.9%). Massive, submassive, 
and minor PE, was diagnosed in 8.2%, 62.3%, and 8.2% 
of patients, respectively. Most patients received anti-
coagulation therapy (95.1%), with thrombolysis and 
embolectomy performed only in smaller proportions 
(24.6% and 11.5%) of patients. Inpatient mortality was 
23.0%. Most patients who died had submassive PE. 
Conclusion: We provide a report of PE cases from a 
SA setting. Our fi ndings have important implications 
related to the management of PE in SA.  
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hospital is situated in a SA province with a high HIV prevalence. 
The patients were identified using the hospital admissions 
database and the International Classification of Diseases 10th 
Revision (ICD-10) code I26 (includes I26.0, I26.9, and sub-
categories thereof). Furthermore, PE was confirmed through 
review of patient computed tomography reports. Patients 
aged <18 years, repeat admissions for PE, existing inpatients at 
IALCH, and patients admitted outside the specified period, 
were excluded from this research. 
Data collection
The medical records of all patients included in this research 
were reviewed, and information related to patient demo-
graphics, clinical presentation, potential risk factors, classifica-
tion and treatment of PE, and inpatient mortality, was collected 
using a paper-based data collection tool. Massive PE was 
defined as PE with haemodynamic instability. Submassive PE 
was defined as PE with haemodynamic stability and evidence 
of right ventricular dysfunction (as per echocardiogram) or 
myocardial necrosis (elevated troponin).(10) Minor PE was 
defined as PE that did not satisfy the criteria for the massive 
or submassive categories. All data were transferred to an elec-
tronic spreadsheet in preparation for statistical analyses. 
Statistical analysis
We analysed our data using descriptive statistical methods. 
Results for the descriptive statistical analysis are presented as 
medians and interquartile range (IQR), or frequencies and per-
centages. We calculated the proportion of cases with inpatient 
mortality, and present this as a percentage with a 95% con-
fidence interval (95% CI). All statistical analyses were per-
formed using the Statistical Package for the Social Sciences 
version 24.0 (IBM Corp, USA). 
Ethical approval
This research received ethical approval from the University 
of KwaZulu-Natal Biomedical Research Ethics Committee 
(BE595/16, BE589/17).
RESULTS
The final CS comprised 61 patients. A description of the CS 
is provided in Table I. The median age of the CS was 48.0 
(IQR: 38.8 - 57.5) years old. Other important demographic 
observations included a preponderance of female cases and 
cases of black African ancestry. Dyspnoea and chest pain were 
the most common clinical symptoms. Tachypnea and tachy-
cardia were the most common clinical signs. One in every 12 
cases presented with haemodynamic instability. Half of all 
cases presented with elevated d-dimers measurements, while 
elevated troponin was observed in almost one-quarter of 
cases. The most common PE risk factors were cardiac failure, 
obesity, and current DVT. Most cases (almost two-thirds of 
cases) presented with submassive PE. Anticoagulation was the 
first choice treatment option, followed by thrombolysis and 
embolectomy.
Figure 1 shows the inpatient survival outcomes of the CS. Of 
the 61 patients in the CS, 14 suffered inpatient mortality (23.0%, 
95% CI: 13.2 - 35.5%). Of the 14 patients who suffered inpatient 
mortality, 3 patients had massive PE, 8 patients had submassive 
PE, no patients had a minor PE, and the PE could not be 
classified in the remaining 3 patients. Of the patients who died, 
most were aged <65 years old (12/14, 85.7%), female (12/14, 
85.7%), and of black African ethnicity (9/14, 64.3%). Dyspnoea 
and chest pain were the most common presenting symptoms 
in those who died, and were reported in 11/14 (78.6%) and 
FIGURE 1: Inpatient survival outcomes.
14 Patients with mortality
47 Patients 
without mortality
61 Patients admitted with PE
3 Massive PE 8 Submassive PE 0 Minor PE 3 Not reported
PE = Pulmonary embolism.
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TABLE I: Description of the CS (N=61).
Characteristic Sub-category n (% of N)




























(Respiratory rate >20 breaths/min)
Yes 29 (47.5)
No 32 (52.5)












O2 saturation (as per pulse oximetry)
≤95% 17 (27.9)
>95% 44 (72.1)




































Not reported 23 (37.7)









































Obesity (body mass index >30kg/m2)
Yes 17 (27.9)
No 14 (23.0)
























CS = Case series, N/A = Not applicable, ED = Emergency department, CCU = Critical care unit, NYHA = New York Heart Association, URL = Upper reference limit, PE = Pulmonary 













6/14 (42.9%) patients, respectively. The most common pre-
senting clinical signs were tachycardia (12/14 patients, 85.7%) 
and tachypnea (9/14 patients, 64.3%). Most patients who died 
were haemodynamically stable on admission (9/14, 64.3%). 
D-dimer and troponin were elevated in 7/14 (50.0%) and 4/14 
(28.6%) patients who died. The most common PE risk factors 
in patients who died were cardiac failure (7/14, 50.0%) and 
obesity (4/14, 28.6%). In patients who died, 85.7% (12/14) 
underwent anticoagulation therapy, 28.6% (4/14) underwent 
embolectomy, and 14.3% (2/14) underwent thrombolysis.
DISCUSSION
There are only a few published CS of VTE from SA settings.(9,11) 
These CS are predominantly comprised of patients with DVT. 
Our CS differs from these in that we report on a much larger 
CS of SA patients with PE. We identified 61 cases who were 
admitted for PE at our institution over a 5-year period. Our 
findings are in line with a previous report on the rarity of PE-
related admissions at SA tertiary-level hospitals.(11) 
Our CS was of similar age to that reported in the SA study of 
Goldstein and Wu.(11) However, our CS was younger than that 
reported for PE in developed countries, such as the United 
States.(12) The younger age of SA patients with VTE (when 
compared with CS in developed countries) can most likely be 
attributed to the high HIV prevalence in SA, and the HIV-
associated coagulopathy in these younger patients.(11) Most of 
our CS was of black African ethnicity and female. This is in 
keeping with existing evidence from both SA and overseas 
settings suggesting a higher incidence of VTE in persons of 
black African ethnicity and in women.(13,14) The basis for the 
higher incidence of VTE among persons of black African 
ethnicity appears to be genetic,(13) while the formation of larger 
platelet aggregates in women has been proposed as an expla-
nation for the higher incidence of VTE in this group.(14)  
The SA study of Goldstein and Wu did not report on the signs 
and symptoms of PE.(11) The most common clinical symptoms 
of PE in our CS were dyspnoea and chest pain, while the most 
common clinical signs in our CS were tachypnea and tachy-
cardia. Our f indings for PE symptoms/signs are similar to 
those reported in the overseas literature, in that tachypnea 
and tachycardia are reported as common clinical signs of 
PE.(4,15) However, the frequency of these reported symptoms/
signs appears to differ between SA and overseas settings. For 
instance, we report a higher frequency of dyspnoea and a 
lower frequency of chest pain when compared with overseas 
settings.(4,15) With regard to PE signs, we report a lower 
frequency of tachypnea, but a higher frequency of tachycardia 
when compared with overseas settings.(4,15) Some clinical symp-
toms/signs are included in clinical prediction rules for PE. 
Therefore, it is possible that clinical prediction scores derived 
from studies performed in other countries may not be appli-
cable in a SA setting. This might necessitate the develop-
ment of setting-specif ic clinical prediction rules for PE.
The most common PE risk factors in our CS were cardiac 
failure and obesity. Our findings are very different from those 
of Goldstein and Wu, who reported HIV and tuberculosis to 
be the most common risk factors in SA patients with VTE.(11) 
It is possible that the preponderance of cases with DVT in 
the study of Goldstein and Wu might be an explanation for 
this difference in findings – as both HIV and tuberculosis were 
found to be the most common risk factors for DVT in another 
SA study.(9) In overseas settings, obesity and a history of DVT 
are the most common PE risk factors, with cardiac failure only 
present in a small proportion of patients.(12) Therefore, we once 
again demonstrate some differences in PE between SA and 
overseas settings. Again, this would also have important diag-
nostic implications in SA settings, with comorbid risk factors 
also contributing to overseas clinical prediction rules.(16)   
The PE population in overseas settings is comprised of patients 
with massive PE, submassive PE, and minor PE in the following 
proportions: 5.0%, 40.0% and 55.0%, respectively.(17) Most 
patients in our CS presented with submassive PE, with massive 
PE and minor PE occurring less frequently. This is in keeping 
with the overseas literature.(17) Almost two-thirds of our CS 
were classified as having submassive PE, with less than 1 in 10 
patients classified as having massive PE according to currently 
accepted definitions, which are based on the presence/absence 
of haemodynamic instability and cardiac dysfunction/injury.(10) 
The presence of haemodynamic instability is often a proxy 
for the degree of occlusion caused by a PE in the pulmonary 
circulation.(10) Our CS suggests that most patients presenting 
with a PE in our setting do not have more severe manifesta-
tions of PE with associated haemodynamic instability. This is 
an important finding that requires confirmation in a prospec-
tive trial. 
Inpatient mortality in our CS was high, even though treatment 
was administered. This agrees with f indings from overseas 
studies, which also report high mortality in patients with PE.(18-21) 
Another important finding of our CS, was that the majority of 
deaths were in patients who had submassive PE (i.e. haemo-
dynamically stable patients). Our findings suggest that in addi-
tion to PE with haemodynamic instability (i.e. massive PE), 
which has traditionally been considered to account for most 
inpatient deaths in overseas settings,(17) PE in haemodynamically 
stable patients might be of concern in SA settings. Haemo-
dynamically stable patients with PE in our setting are potentially 
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salvageable, and our findings suggest that they should be con-
sidered for more aggressive management. As in overseas set-
tings,(10) anticoagulation therapy formed the backbone of PE 
treatment in SA patients. Also in keeping with overseas man-
agement practices, intervention by thrombolysis or embolec-
tomy was only performed when there was a relevant indica-
tion to perform either of these interventions.(10,22) 
A limitation of our CS is that our modest sample size pre-
vented us from performing further statistical investigations of 
characteristics associated with inpatient mortality. Another 
limitation of our CS is that it was from a single, tertiary-level 
healthcare facility. Therefore, our findings might not be appli-
cable to SA patients with PE attending lower-level healthcare 
facilities. We chose to include only patients who were admitted 
with a primary diagnosis of PE (and not patients who were 
existing inpatients) in our CS. This might have introduced 
selection bias into the research. Due to the retrospective 
nature of this CS, there might have been under-reporting of 
some PE symptoms/signs. Another potential limitation of our 
CS is that the data capture of ICD primary diagnosis codes 
might have been incorrect, and there might have been some 
admissions for PE that were missed. Data were missing for 
some characteristics; however, we did not exclude patients 
with missing data from our analysis and accounted for missing 
data with the “not reported” category. Finally, we only report 
on inpatient outcomes and do not report patient outcomes 
following discharge from hospital. Large, multicentre, pro-
spective studies are required to address the afore-mentioned 
limitations.
CONCLUSION
We provide a report of PE in SA patients. There were differ-
ences in PE presentation and risk factors between SA and 
overseas settings. Some clinical symptoms/signs and risk fac-
tors are included in clinical prediction rules for PE that were 
derived in overseas settings. If there are differences in PE clin-
ical symptoms/signs and risk factors between SA and overseas 
populations, then overseas clinical prediction rules might be 
inappropriate for application in SA settings. Setting-specific 
clinical prediction rules for PE might be required. Inpatient 
mortality in SA patients with PE was high, even when treatment 
was administered. Most patients who died had submassive 
PE. As patients with submassive PE are haemodynamically 
stable, they are potentially salvageable. These patients should 
be considered for more aggressive management. Further 
research is required to confirm our f indings, as well as to 
address the limitations of our research.
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